504 related articles for article (PubMed ID: 30470613)
21. Mitochondria are devoid of amyloid β-protein (Aβ)-producing secretases: Evidence for unlikely occurrence within mitochondria of Aβ generation from amyloid precursor protein.
Mamada N; Tanokashira D; Ishii K; Tamaoka A; Araki W
Biochem Biophys Res Commun; 2017 Apr; 486(2):321-328. PubMed ID: 28302486
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
23. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
24. Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.
Zhang SQ; Sawmiller D; Li S; Rezai-Zadeh K; Hou H; Zhou S; Shytle D; Giunta B; Fernandez F; Mori T; Tan J
PLoS One; 2013; 8(8):e71913. PubMed ID: 23977176
[TBL] [Abstract][Full Text] [Related]
25. C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively.
Xie H; Xiao Z; Huang J
J Mol Neurosci; 2016 Jul; 59(3):334-42. PubMed ID: 26614345
[TBL] [Abstract][Full Text] [Related]
26. Proximity ligation assay reveals both pre- and postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain.
Lundgren JL; Vandermeulen L; Sandebring-Matton A; Ahmed S; Winblad B; Di Luca M; Tjernberg LO; Marcello E; Frykman S
BMC Neurosci; 2020 Feb; 21(1):6. PubMed ID: 32019490
[TBL] [Abstract][Full Text] [Related]
27. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.
Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY
Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826
[TBL] [Abstract][Full Text] [Related]
28. Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway.
Milosch N; Tanriöver G; Kundu A; Rami A; François JC; Baumkötter F; Weyer SW; Samanta A; Jäschke A; Brod F; Buchholz CJ; Kins S; Behl C; Müller UC; Kögel D
Cell Death Dis; 2014 Aug; 5(8):e1391. PubMed ID: 25165877
[TBL] [Abstract][Full Text] [Related]
29. GDE2-RECK controls ADAM10 α-secretase-mediated cleavage of amyloid precursor protein.
Nakamura M; Li Y; Choi BR; Matas-Rico E; Troncoso J; Takahashi C; Sockanathan S
Sci Transl Med; 2021 Mar; 13(585):. PubMed ID: 33731436
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.
Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C
Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420
[TBL] [Abstract][Full Text] [Related]
31. 5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.
Cochet M; Donneger R; Cassier E; Gaven F; Lichtenthaler SF; Marin P; Bockaert J; Dumuis A; Claeysen S
ACS Chem Neurosci; 2013 Jan; 4(1):130-40. PubMed ID: 23336052
[TBL] [Abstract][Full Text] [Related]
32. Extracellular-Signal-Regulated Kinase Inhibition Switches APP Processing from β- to α-Secretase under Oxidative Stress: Modulation of ADAM10 by SIRT1/NF-κB Signaling.
Thonda S; Puttapaka SN; Kona SV; Kalivendi SV
ACS Chem Neurosci; 2021 Nov; 12(21):4175-4186. PubMed ID: 34647720
[TBL] [Abstract][Full Text] [Related]
33. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease.
Al-Atrache Z; Lopez DB; Hingley ST; Appelt DM
BMC Neurosci; 2019 Feb; 20(1):6. PubMed ID: 30786875
[TBL] [Abstract][Full Text] [Related]
34. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α.
Durairajan SS; Liu LF; Lu JH; Koo I; Maruyama K; Chung SK; Huang JD; Li M
J Alzheimers Dis; 2011; 25(2):245-62. PubMed ID: 21403388
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases.
Jacobsen KT; Adlerz L; Multhaup G; Iverfeldt K
J Biol Chem; 2010 Apr; 285(14):10223-31. PubMed ID: 20139073
[TBL] [Abstract][Full Text] [Related]
37. Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.
Lim S; Yoo BK; Kim HS; Gilmore HL; Lee Y; Lee HP; Kim SJ; Letterio J; Lee HG
BMC Cancer; 2014 Dec; 14():928. PubMed ID: 25491510
[TBL] [Abstract][Full Text] [Related]
38. Alcadein cleavages by amyloid beta-precursor protein (APP) alpha- and gamma-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related gamma-secretase dysfunction.
Hata S; Fujishige S; Araki Y; Kato N; Araseki M; Nishimura M; Hartmann D; Saftig P; Fahrenholz F; Taniguchi M; Urakami K; Akatsu H; Martins RN; Yamamoto K; Maeda M; Yamamoto T; Nakaya T; Gandy S; Suzuki T
J Biol Chem; 2009 Dec; 284(52):36024-36033. PubMed ID: 19864413
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of APP, ADAM10 and ADAM17 in the denervated mouse dentate gyrus.
Del Turco D; Schlaudraff J; Bonin M; Deller T
PLoS One; 2014; 9(1):e84962. PubMed ID: 24404197
[TBL] [Abstract][Full Text] [Related]
40. Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis.
Trerotola M; Guerra E; Ali Z; Aloisi AL; Ceci M; Simeone P; Acciarito A; Zanna P; Vacca G; D'Amore A; Boujnah K; Garbo V; Moschella A; Lattanzio R; Alberti S
Neoplasia; 2021 Apr; 23(4):415-428. PubMed ID: 33839455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
